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INTRODUCTION
Small  single  enhancing  lesion  in  CT  (SSECT)scan  as  an  entity  came  into 
existence in India in early 1980, with the advent of CT scan. Tandon etal3 labeled them 
as  intracranial  tuberculomas.  They  identified  two  types  of  lesions  based  on  the 
appearance of the lesion in the C T Scan brain. Small ring and disc lesions were called 
as  immature  tuberculomas  and  large  lobulated  lesions  were  called  as  mature 
tuberculomas. ATT was invariably started in these patients. Sethi etal5 & Bansal etal6 
noted  that  these  lesions  disappeared spontaneously  without  treatment.  Natarajan  and 
Arjundas  etal37 at  the  Institute  of  Neurology,  Chennai  also  noted  spontaneous 
disappearance of these lesions without specific treatment. 
The  exact  cause  of  these  lesions  could not  be deciphered  because  apart  from 
tuberculoma, cysticercus granuloma, pyogenic abscess, metastases, fungal granuloma, 
and glioma had been reported to cause similar appearance in CT scan brain as more 
centers acquired C.T.Scan facility. Hence the exact aetiology of these lesions became a 
subject of speculation. A significant breakthrough came in 1987 at Vellore 8 when stereo 
tactic biopsy was done on 15 patients with SSECT. Most of the lesions were identified 
as cysticercus and none were of tuberculous etiology. Bhargava and Tandon in 1988 and 
Wadia, Makhalle in 19863,4,  found evidence of tuberculous lesions in histopathology. 
However they failed in defining the size of the lesion. Rajshekhar etal8  then defined a 
small single lesion based on CT appearance as “A solitary, contrast-enhancing lesion of 
less than 20-mm diameter lesion without severe cerebral edema (no midline shift)”.this 
definition is often equated to cysticercous granuloma but there is every possibility that 
these lesions could be a tuberculoma. 
There is no consensus in terms of aetiology of these small lesions. The common 
presentation of SSECT is seizures. The seizures are acute symptomatic in nature and the 
duration of antiepileptic treatment is once again controversial. Murthy etal and Thussu A 
etal  34  35 reported  that  AED can  be  tapered  and  stopped  if  the  lesion  had  resolved 
radiologically. In patients who had radiological resolution AED  was given for 6 months 
and then tapered over 3 months.  They also construed that lesions which resolved with 
calcification is a risk factor for seizure recurrence. Gupta Met al 38 compared short term, 
(6  months  AED)  with  long  duration,  (2years  AED)  and  they  found  no  significant 
recurrence in seizures with both forms of therapy. Though lot of work has been done 
with regards to aetiology of single lesion there is no consensus regarding the duration of 
AED requirement. 
The  purpose  of  this  study  is  to  treat  SSECT symptomatically  and  follow the 
natural course of the lesion over a period of one year in terms of its  resolution and 
symptom improvement. The end points were clinical and radiological outcome.
                                
REVIEW OF LITERATURE
                                 DEFINITION OF SSECT
             Amongst single contrast enhancing lesions on CT Scan Brain, those less than 20 
mm were classified as small and termed “single small enhancing computed tomography 
lesion”  (or  SSECT).  The  criteria  for  SSECT  included  patients  who  had  acute 
symptomatic  focal  seizures with or  without secondary generalization,  minimal  or  no 
neurological  deficit,  no  evidence  of  raised  intracranial  tension  and  no  evidence  of 
systemic disease4, 7, 9, 10.
A Thailand based study evaluated 1,000 patients with various seizure disorders, of 
whom approximately 10% had seizure and a solitary lesion. Roughly 80% of patients 
had  lesions  more  than  20  mm and  were  excluded.  On follow-up of  these  excluded 
patients (> 20 mm), only 1 had spontaneous resolution while the rest had persistent 
lesion on CT scan. Of the remaining 20% included in the study, 90% had complete 
resolution  by  6  months.  Of  the  two  patients  with  persistent  lesions,  one  underwent 
excision  biopsy  which  revealed  eosinophilic  granuloma.  The  other  patient  refused 
biopsy, anti-tubercular treatment was prescribed and lesion disappeared in 4 months. 
This study concluded that a small lesion of less than 20 mm in size is a cysticercous 
granuloma,  because  the  lesions  were  classified  based  on  Rajshekhar’s  clinico 
radiological definition for Cysticercus granuloma. 
CAUSES OF SINGLE ENHANCING LESION IN CONTRAST CT SCAN:
COMMON:
Cysticercus granuloma.
Tuberculoma.
UNCOMMON:
Glioma
Secondary disease
Cryptic AVM
Brain abscess
Larva migrans
Sarcoidosis
Small infarct
Focal encephalitis
IN IMMUNOCOMPROMISED PATIENTS:
Toxoplasmosis
CNS lymphoma
Fungal granuloma.
However  in  Indian  subcontinent  the  commonest  cause  for  a  small  single  enhancing 
lesion is either a tuberculoma or a cysticercoma. An attempt was made to differentiate 
between these two entities based on clinical and radiological features.3,4,6,8.
                     CLINICORADIOLOGICAL DEFINITION
              Since SSECT is a clinico radiological entity, the diagnostic dilemma begins 
when either an asymptomatic or symptomatic patient (usually with focal seizures) shows 
a  characteristic small (< 20 mm) lesion on CT which enhances with contrast. The initial 
differentiating features are accompanying radiological characteristics of the lesion.
The  characteristic  lesion  on  a  plain  CT of  neurocysticercosis  is  a  small  high 
attenuation  lesion  surrounded by  peri-lesional  edema  or  only  low attenuation  lesion 
depicting focal edema.
With contrast the lesion may enhance as a ring, disc, or target lesion. The shape 
may be ovoid, doughnut-like or bi-lobed in some cases. There is no or minimal mass 
effect. There is no specific site of predilection. Some studies indicate a predilection to 
frontoparietal  regions.  However,  most  of these lesions are  situated at  the gray-white 
matter junction 2. 3, 5, 9.
DIFFERENCE  BETWEEN  CYSTICERCOMA  &TUBERCULOMA  AND  THE 
CONTROVERSIES
Tuberculomas are usually irregular, solid and greater than 20 mm in size. They 
are  often  associated  with  severe  perifocal  edema  and  focal  neurological  deficit. 
Regarding the diagnostic criteria of solitary cysticercus granuloma given by Rajshekhar 
and Chandy7,8 there are several controversies which need to be highlighted. No study has 
been done to evaluate the spontaneous disappearance of lesions greater than 20 mm till 
now. Moreover, no histopathological study has ever demonstrated that all large lesions 
(>20  mm)  are  tuberculomas.  On  the  contrary,  every  retrospective  and  prospective 
follow-up study  of  single  enhancing CT lesions  in  patients  with  new-onset  seizures 
observed the spontaneous resolution of the lesions irrespective of their size, shape and 
amount of surrounding edema. In fact, several series which included patients with CT 
lesions  of  varied  sizes,  shapes  and perifocal  edema,  identical  favorable  clinical  and 
radiological courses were obtained. 
Some  studies  showed,  small  single  enhancing  CT  lesions  were  treated  with 
antituberculous treatment with excellent results and this adds to the controversy of the 
etiology of single enhancing CT lesions. Even if a patient does not fulfill the diagnostic 
criteria given by Rajshekhar and Chandy  7,8, it does not comprehensively exclude the 
possibility of a cysticercus etiology, and vice versa. In addition to the features suggested 
by Rajshekhar and Chandy 7,8, several other differentiating imaging features have been 
suggested from time to time. For example, in these contrast enhancing lesions, "target 
lesions" (lesions with central nidus of calcification or a dot enhancement) are frequently 
encountered. Earlier, target lesions were considered a pathognomonic feature of CNS 
tuberculoma3. Del Brutto et al 28,29 and some other authors reported that visualization of 
an  enhancing  or  a  calcified  eccentric  dot  which  represented  the  scolex,  could  be 
considered  a  definite  imaging  feature  of  cysticercus  etiology,  unfortunately 
histopathology evaluation of these target lesions is not available 7,8. 
SSECT, criteria as proposed by Chandy  et  al  7,8 in 1991.  All  criteria must  be 
satisfied for a diagnosis of SSECT.
The clinical criteria are:
1. Seizures (partial or generalized) should be the initial symptom.
2. There should be no features of persistently raised intracranial pressure.
3. There should be no history of a progressive neurological deficit.
4. There should be no evidence of an active systemic disease.
The radiological criteria are:
1. CT scan should only show a solitary, contrast enhancing lesion.
2. The lesion should measure less than 20 mm in maximal diameter.
3. Edema may or may not be present, but is not severe enough to produce a shift of the 
midline structures.
These clinico-radiological criteria were found highly sensitive and specific in predicting 
benign outcome 7 8.
                                       ROLE OF BIOPSY
A major breakthrough in the understanding of these single CT-enhancing lesions 
came when Chandy, et al.,7,8reported obtaining CT-guided stereotactic biopsy samples. 
Histopathological  examination  of  these  brain  tissue  samples  showed  cysticercal 
granuloma in the majority of patients. In another study of 51 patients Rajshekhar, et 
al.,7,8 documented cysticercal granulomas in 25 patients and tuberculoma in six cases in 
biopsy.  Of  the  remaining  20  patients,  12  patients  harbored  parasitic  granuloma 
(cysticercal lesion not definite), six patients nonspecific inflammation, and one patient 
each had dystrophic calcification and secondary metastasis. The authors concluded that 
the majority of single enhancing CT lesions are caused by neurocysticercosis. However, 
other  diseases  such  as  tuberculoma  should  always  be  considered  in  the  differential 
diagnosis.
A study carried out by Chacko et al showed on histopathology,
1. A cavitary inflammatory lesion,
2. Presence of eosinophils in inflammatory infiltrate,
3. Absence of caseous necrosis, and
4. Absence of acid-fast bacilli (AFB) or fungal elements.
They also performed 5 micrometre deeper sections in 6 patients which showed calcified 
ovoid bodies, structurally similar to intracorporeal vacuoles, which also suggested the 
possibility of cysticercosis.
These different studies vindicated the stand that a small enhancing lesion is most likely 
to be a cysticercous granuloma 7, 8.
                                   ROLE OF BIOCHEMICAL TESTS
Immunological tests for tuberculosis, neurocysticercosis, or toxoplasmosis have 
limitations as these organisms are seen even in normal individuals in most countries of 
the developing world. The tuberculin test is of poor diagnostic use as 40% of the adult 
population may be positive due to prior exposure. The results of conventional ELISA for 
cysticercus antibodies in serum and CSF of patients with SSECT have been generally 
disappointing (sensitivity of 50% and a specificity of 65%). Serological tests are useful 
if positive, but negative test results do not rule out the disease. False positive serology 
can  result  from  previous  infection.  False  negative  serology  can  result  because  of 
immune tolerance, inactive disease, or localized antibody production in the CSF. The 
newer enzyme-linked immunoelectrotransfer blot (EITB) assays on serum or CSF using 
purified  glycoprotein  antigens  from  T.  solium cysticerci  have  claimed  much  higher 
sensitivity  and  specificity  of  98%  and  100%  for  multiple  active  cysts  and 
extraparenchymal  NCC,  but  sensitivity  is  less  in  calcifications  or  single  cysts, 
respectively in LatinAmerica21,26.
If there is associated tubercular meningitis, raised CSF proteins, normal sugar and 
lymphocytosis may be seen. CSF findings in neurocysticercosis include mononuclear 
pleocytosis,  normal  glucose  levels,  elevated  protein  levels,  high  immunoglobulin  G 
index, and in some cases presence of oligoclonal bands. 
Sotelo et al 24,25 in a study of 753 cases observed that demonstration of eosinophils 
in CSF, though not pathognomic, was valuable indirect evidence of neurocysticercosis. 
When  CSF  was  inflammatory,  eosinophils  were  found  in  57.7% of  cases.  Far  less 
specific, but still another frequent finding was hypoglycorrhachia detected in 17.7% of 
the cases with inflammatory CSF. The above findings were absent in non-inflammatory 
CSF. 
However, if the disease is limited to the brain parenchyma, CSF examination may 
be normal, as is expected in the majority. CSF in effect may just say whether there is 
inflammatory or a noninflammatory lesion in the brain and does not aid in the diagnosis 
24, 25.
LIFE CYCLE
Taeniasis  and cysticercosis  remain a global  public health  problem in both the 
developing and developed countries. Infection is becoming increasingly common in the 
latter  because  of  the  increasing  immigration  and  more  frequent  travel  to  regions  of 
endemic  disease.  These  parasitic  diseases  are  related  to  poverty  and  poor  sanitary 
infrastructure. Therefore, cysticercosis has been designated as a biological marker of the 
social and economic development of a community. 
BIOLOGY
Humans are  the only  known host  to  harbor  the adult  cestode  parasite,  Taenia 
solium, in the intestine. Infection is acquired by ingesting undercooked pork infected 
with Taenia larvae (ie, cysticerci). The cysticerci evaginate into the intestines where they 
mature into adult worms. The worms consist of a scolex, which attaches itself to the 
intestinal wall, and numerous proglottids (ie, segments). Proglottids and eggs are shed 
intermittently into the stool. 
The intermediate host, typically the pig, is infected by ingesting parasite eggs or 
proglottids containing eggs (ie, porcine cysticercosis). The oncospheres escape from the 
eggs, penetrate the intestinal mucosa, migrate through the bloodstream, and lodge in the 
tissues.  Over weeks to months,  they evolve into larvae that  enlarge and mature into 
cysticerci. The life cycle is completed when humans ingest pork contaminated with the 
cysts. 
Human cysticercosis  is  acquired after  eating food contaminated with fertilized 
eggs excreted in the feces of  Taenia carriers. In humans, the most common routes of 
infection are ingestion of T solium eggs from contaminated food and rarely from fecal-
oral autoinfestation from patients harboring the adult parasite in their intestines. While 
the  cysts  can develop in  any human tissue,  they  have a  predilection for  the  central 
nervous system (CNS), skeletal muscle, subcutaneous tissue, and eyes 9. 
                                         IMMUNE RESPONSE 
In humans and pigs, the cysticerci may live within the host tissue without causing 
inflammation or disease. The immune response is unpredictable and may vary from a 
complete tolerance to an intense immune response. A single patient may show an intense 
inflammation  around a  cyst  at  any  stage  of  the  degeneration  process,  together  with 
viable cysts with lack of inflammation and several calcifications scattered in the brain. 
Autopsies of victims of warfare and road/traffic accidents have revealed that a large 
proportion of NC infection is asymptomatic and discovered incidentally at necropsy. 
Individuals who undergo computed tomography (CT) of the head for unrelated reasons 
(eg, head injury) may demonstrate multiple parenchymal calcifications. 
Several studies have analyzed the mechanisms of the immune response elicited 
against T solium cysticercus, such as the heterogeneity of the humoral immune response, 
the existence of immune evasive mechanisms, and the fact that the immune response can 
both protect and harm the host. 
The humoral immune response to antigens of T solium cysticerci is evident from 
the number of immunodiagnostic assays that have been developed using different types 
of antigens. Several immunoglobulin (Ig) classes are produced as specific antibodies 
against  the  parasite.  The  most  frequent  is  immunoglobulin  G  (IgG),  which  can  be 
detected in serum, CSF, and saliva and suggests that infection is of long duration. The 
immune response against  T solium cysticerci appears to have components of both T 
helper  type  1  cells  (Th1)  and T helper  type  2  cells  (Th2),  although the  underlying 
mechanisms are yet to be clarified. The parasite is probably killed by eosinophils, which 
are attracted to the site by lymphoid cells. It is assumed that this specific response is 
mediated by Th2 cytokines 16, 21, 26. 
                                       PATHOPHYSIOLOGY 
The natural history of cysticerci in the CNS is not entirely understood. CT scan 
and magnetic resonance imaging (MRI) have been useful in the study of the evolution of 
the  cysticercus  within  the  brain  parenchyma.  MRI  is  more  useful  than  CT scan  in 
detecting intraventricular and subarachnoidal cysts, as well as the accompanying signs 
of  cyst  degeneration  and  pericystic  inflammatory  reaction.  However,  CT  scan  is 
preferred for detection of parenchymal calcifications. Once the oncosphere has passed 
into the parenchyma, it grows and evolves through vesicular, colloidal, nodular-granular, 
and calcified phases. 
After entering into the brain parenchyma, the parasite develops into a “vesicular 
stage” in which the cysts are viable and elicit  very little inflammatory response in the 
surrounding brain tissue. On CT scanning viable cysticercal lesions appear as rounded, 
circumscribed, hypodense lesions, and contrast enhancement is absent. After a variable 
period of time the parasite loses its viability either because of aging, inability of larva to 
become adult, or immunological factors particular to the host, and it enters into the next 
stage 9.
The second phase is the “colloidal stage” in which inflammatory changes develop 
in the cyst wall and surrounding brain parenchyma. Transparent cystic fluid is replaced 
by jellylike whitish material, which is surrounded by a fibrous capsule. This dying stage 
of larva is referred to as cysticercal granuloma. In this stage, CT scanning demonstrates 
a ring-enhancing lesion. Progressive reduction in the size of the cyst and scolex and 
mineralization of cystic fluid lead to development of a “granular-nodular” stage in which 
the larva appears as a disc-enhancing lesion on contrast-enhanced CT.
 In the last "calcific stage" the lesion becomes completely mineralized and appears 
as a hyperdense calcified nodule on plain CT scanning. At this stage there is no contrast 
enhancement  and  surrounding  edema  is  also  absent  because  of  abatement  of 
inflammation 9.
                                      CLINICAL FEATURES
Symptoms of nervous system involvement depend upon the (1) site of the cyst (2) 
& number of the larva or (3) State of the lesion activity & (4) host immune response. 
Common presentations in chronological order of incidence is given below,
Seizure
Headache 
Papilloedema 
Pyramidal tract signs 
Intellectual deterioration 
Ataxic gait 
Diminution of visual acuity 
Optic atrophy 
Psychotic episodes 
Diplopia 
Vertigo 
Dysmetria or intention tremor 
Lower cranial nerve palsy (VII to XII) 
Disturbances of behavior 
Hypoaesthesia 
Decreased hearing 
Spinal cord compression 
Meningeal irritation signs 
Radicular syndrome 
Parinaud’s syndrome.
Epilepsy  and  headache  formed  95%  of  the  clinical  manifestations  and  epilepsy 
accounted for 52.4% 1 2 4 6 7
TO TREAT OR NOT TO TREAT
Single enhancing lesions:
                                                  Start AED
Repeat CT after 2-3 months 
Lesion 
persists or 
enlarges
Lesion 
calcified 
Start AED Albendazole Continue AED for 2- 3 
years
Lesion 
disappeared
The algorithm says that a single lesion need not be treated with cysticidal drugs 10 
11 18. However in a study conducted by  Albendazole therapy for single small enhancing 
CT lesion  (SSECT) in  brain  in  epilepsy  A Thussu,  etal  1,the  conclusion  drawn was 
patients presenting with seizures due to single parenchymal NCC, albendazole hastens 
resolution of SSECT if treatment is given in the early phase of illness 1.
The question then arises should a single lesion be treated with albendazole or 
Lesion 
persists or 
enlarges
Lesion 
calcified 
Start AED Albendazole
Seizures 
uncontrolled or 
neurological 
deficit
Seizures 
controlled
Continue AED And
Repeat CT after 6 
months
Biopsy 
of lesion
Continue 
AED for 2- 3 
years
praziquantel or not at all. The question of treating or not treating a single lesion arose 
because  of  the  radiological  resolution  which  occurred  spontaneously.  The  most 
remarkable  feature  of  single  enhancing  lesions  observed  on  CT  scanning  is  their 
complete  spontaneous  disappearance  in  the  majority  of  patients,  as  well  as  their 
occasional significant reduction in size in others. The edema surrounding the lesion is 
usually  the  first  to  resolve.  Later,  the  lesion  may  disappear  completely,  leaving  no 
residue, or it may leave a tiny speck of calcification at the former site of the lesion. In 
some patients the granulomatous lesion transforms into a calcified nodule. Controversy 
exists regarding the exact time that these CT-enhancing lesions disappear. In several 
retrospective studies the authors have suggested that spontaneous resolution may vary 
from as early as 6 weeks to as late as 75 weeks.  Even greater  persistence has been 
observed.  Various  authors  have  noted  a  wide  variation  in  the  rates  of  complete 
resolution. The rate of disappearance has ranged from 22 to 100% at 12 weeks after 
detection  on  the  first  CT  scan.  Addressing  this  same  issue,  Rajshekhar  7,8, 32  in  a 
prospective study of 210 patients,  observed that single enhancing lesions completely 
resolved at different time intervals.  At 3 months only 19% of lesion had completely 
resolved; at 1 year approximately 63% had disappeared. In another prospective study, 
which supports majority opinion, Singh, et al.,4 6 observed that approximately 73% of 
similar-appearing  lesions  had  disappeared  within  2  months  of  their  first  CT 
documentation. 
In Latin American countries, CT-depicted single enhancing lesions are invariably 
treated either with albendazole or praziquantel. In an uncontrolled study Del Brutto 28,29 
observed early resolution of lesions on CT scans following  treatment with albendazole. 
More recently, in a controlled study, Pretell, et al.,28 included 26 patients with single 
enhancing  lesions.  The  patients  were  openly  assigned  to  receive  either  single-day 
praziquantel therapy (three doses of 25 mg/kg at 2-hour intervals) or no treatment. In 
praziquantel-treated patients, complete resolution occurred in 11 and partial resolution in 
two, in the remaining patient the lesion was later diagnosed as AVM. Conversely, the 
lesions persisted unchanged in six of 12 patients in the non treatment group. The authors 
favored routine administration of anticysticercal drugs in patients with single enhancing 
lesions. Although this single-day praziquantel therapy has been found particularly useful 
for  single  lesions,  poor  response  has  been  noted  in  those  with  multiple  cysticercal 
lesions 11 12 13 14 17.
In  India,  studies  involving  anticysticercal  treatment  have  provided  conflicting 
results. In a placebo-controlled study Padma, et al., observed that 7-day treatment with 
albendazole did not hasten the resolution of CT-documented lesions  18.  In a different 
double-blind  placebo  controlled  study,  however,  Baranwal,  et  al.,  observed  a 
significantly  faster  and  higher  incidence  of  complete  disappearance  of  lesions  in 
children who underwent 28-day albendazole treatment (15mg/kg/day). The conflicting 
results of these two studies also fueled the controversy of the ideal dosage regimen of 
albendazole.  A  comparative  study  is  needed  to  evaluate  7-  or  8-day  albendazole 
treatment in a 30-day course in patients with single CT-enhancing lesion. In patients 
with  other  forms  of  NCC,  Cruz,  et  al,  14 have  already  demonstrated  that  8  day 
albendazole treatment is as effective as 15- or 30-day therapy. These authors concluded 
that there is no benefit to extending albendazole treatment beyond 7 or 8 days 11 12 13 14 17.
                      PRAZIQUANTEL OR ALBENDAZOLE
As demonstrated  by  experiments  in  animals,  praziquantel  and albendazole  are 
both effective antiparasitic drugs against T. solium cysticerci. The issue is which drug is 
better, or how long is it to be given, and at what dosage it has to be taken. Initial studies 
began treatment with praziquantel  with low doses like 5-10 mg/kg/day for  2 weeks, 
while later studies uniformly adopted 50 mg/kg/day for 2 weeks. Some studies even 
used a single dose praziquantel treatment,  and there was no difference in the rate of 
disappearance  of  the  cysts.  When  Albendazole  became  available,  no  dose  ranging 
studies were performed for it and the dose used in Hydatid cyst (15 mg/kg/day) was also 
used  for  cysticercosis.  The  advantages of  albendazole  over  praziquantel  are  that  the 
former is orally available as a once daily dose, has a better penetration into the CSF, its 
concentration is not affected when given with steroids, and it is cheaper as compared to 
the latter 11 12 13 14 17.
PROS AND CONS FOR ATT/ANTI NCC TREATMENT
1) Rapid disappearance of cysts – no conclusive evidence in better epilepsy control.
2) Severe cases seen less frequently now – may be not due to cysticidals but due to 
improved sanitations and fewer mass infections.
3) Series of albendazole or praziquantel treated patients have better resolution (fewer 
seizures)  than  untreated  patients  seen  at  the  same  centres  -  inadequate  control 
groups in initial studies.
4) Fewer residual calcifications - No evidence that anti-cysticercal therapy results in 
fewer calcifications.
PROS AND CONS FOR SYMPTOMATIC TREATMENT
1) NCC becomes symptomatic after a period of years as a result of onset of process of 
death  of  parasite.  –  Questionable  methodology  as  some  patients  persist  with 
symptoms and live with cysts for years.
2) Anti-cysticercal therapy leads to acute cerebral Inflammation and this therapy is 
thus severe and unnecessary. Inflammation can be controlled with steroids; chronic 
inflammation, and moderate inflammation may lead to scars similar to or worse 
than those from a short, acute, severe process.
3) Adverse reaction to treatment 27.
DURATION  OF  ANTIEPILEPTIC  DRUGS  IN  SMALL  SINGLE 
ENHANCING LESIONS IN CT BRAIN
The duration of antiepileptic drug therapy in patients with Small single enhancing 
lesion in CT brain has not been clearly worked out. SSECT is the commonest cause of 
acute symptomatic seizures. 
Thussu etal  35 compared short term (6months) antiepileptic treatment with long 
term antiepileptic  treatment  (2  years)  in  two groups  of  patients.  In  both  the  groups 
patients who had resolution in CT brain at 3 months had no further seizures. They also 
found that calcified lesions were associated with seizure recurrence. 
Among  34  patients  with  calcifications  in  both  the  groups,  11  patients  had 
recurrent  seizures.  Among these 11 patients  8  patients  belonged to  short  term AED 
group while 3 patients belonged to long term AED group. The difference between both 
the groups did not attain statistical significance. They concluded that calcified lesions 
have a high frequency of seizure recurrence and the duration of AED treatment in these 
cases is conjectural at present. 
The adequate duration of treatment in such cases is an individual prerogative of 
the treating physician35. Murthy et al expressed similar views in a retrospective analysis 
of  102  patients  with  small  single  enhancing  lesions.34 Antiepileptic  drugs  are  the 
principal therapy for seizures in SSECT. In general, seizures should be managed in a 
manner  similar  to  the  management  of  acute  symptomatic  seizure.  However,  after 
resolution of the lesion with normalization of imaging studies, most patients who are 
seizure-free can eventually discontinue antiepileptic drugs. Antiparasitic drugs should 
not be regarded as an alternative for antiepileptic drug therapy 36. 
                         AIMS AND OBJECTIVES
1) To study the natural course of SSECT without giving cysticidal or anti tuberculous 
treatment and give only symptomatic treatment as needed.
2) To observe the seizure outcome in patients with SSECT, duration of persistence or 
subsidence  of  symptoms  and  to  find  out  the  duration  of  symptomatic  treatment 
needed.
3) To follow the patients with SSECT radiologically at 3months,6 months and 1 year to 
assess the size, morphology, occurrence of calcification and resolution characteristics 
in CT brain. Identifying the aetiology was not part of this study as tissue study by 
biopsy is the only conclusive test for a definitive diagnosis.
                   
MATERIALS AND METHODS
           The study was done at the Institute of  Neurology  Government General Hospital, 
Chennai.  The  study  had  collaborations  with  the  Institutes  of  Internal  Medicine, 
Biochemistry, Radiology and Microbiology attached to government general hospital. 
          
           This  study was observational in nature designed to analyze patients in age group 
more  than 12 years  of  age and who presented with seizures and CT brain showing 
SSECT.  The  sample  size  was  26  and  the  study  period  was  from Dec  2005  to  Jan 
2008,including the follow up.
Inclusion criteria: 
1. All patients who have SSECT lesions in the brain, detected by CT scan.
2. The patients should not have other neurological problems.
Exclusion criteria:
1. Patients who have neurological problems other than due to the small single enhancing 
lesion of the brain.
2. More than 2 lesions on CT brain.
3. Patients age less than 12 years and pregnant women.
METHOD OF THE STUDY
The clinical  diagnosis  on the seizure  type,  whether  partial  or  generalized was 
made. A detailed history was taken and recorded. Significant past medical history if any 
were noted. A thorough clinical examination was performed at the time of admission 
and relevant findings were recorded. Laboratory work up, which included blood sugar, 
urea, serum creatinine, electrolytes and liver function tests (if indicated), were done at 
the time of enrollment into the study .Patients with CT brain showing single enhancing 
lesion  were  enrolled  in  the  study  after  taking  consent.   Consent  was  taken  after 
explaining the therepeutical aspects. 
They were followed for 1 year with respect to seizure control and CT evolution of 
the lesion. All patients were treated with antiepileptic drugs(AED). Steroids at 1mg per 
kg body weight were added to patients who had lesions with oedema. It was tapered 
over a period of 15 days given. Follow up CT scans with contrast was done at the end of 
3rd month,  6th month and 1 year if required. The lesions were followed in terms of 
regression, persistence, enlargement, resolution and calcification. 
RESULTS
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DISCUSSION
 The study included 25 patients of different age and sex. Sex ratio was almost 
even (men-14–56% women 11 –44%). The youngest patient was 13, and the oldest was 
65 years old. 
The  analysis  of  the age groups  showed that  the incidence of  SSECT is  more 
common among the younger age group. As the age advances the incidence decreases. 
This data is concordant with other studies 1 2 4 6.
SEIZURE SEMIOLOGY AND SEIZURE OUTCOME
Among the 25 patients encountered in this study, 13(52%) patients presented with 
generalized  tonic  clonic  convulsions  and  7(28%)  presented  with  focal  seizure  with 
secondary  generalization.  3  patients  presented  with  complex  partial  seizure  with 
secondary  generalization,  while  two  patients  presented  with  focal  seizures.  Several 
studies  implicated  focal  seizures  with  secondary  generalization  as  a  common 
presentation of SSECT. A Thussu, A Chattopadhyay, IM S Sawhney in their study of 
albendazole  as  monotherapy  in  SSECT  also  noted  focal  seizure  with  secondary 
generalization as the commonest presentation 1.
In some studies GTCS was the commonest presentation. Venkataraman et al19, in 
their  study  found  GTCS as  a  commonest  presentation.  In  our  study  GTCS was  the 
common presentation. 4 patients presented with cluster seizures and 3 patients presented 
with status. All these patients had significant edema in CT brain. The occurrence of 
cluster seizures and status could be attributed to the presence of vasogenic edema, which 
by itself is due to the immunological reaction of the dying parasite and break down of 
the blood brain barrier.
Patients  were  treated  as  acute  symptomatic  seizures.  Steroids  were  added  to 
patients who had significant oedema in CT. All the patients were followed for 1 year.14 
(56%) patients became seizure free by 3 months. Among these 14 patients ,12 patients 
had complete resolution of their lesion in CT scan.11 patients were having seizures. 
Among these patients 3 had calcifications, 2 patients had an increased size while the 
others had decreased size of the lesion. Seizure semiology did not change in any of the 
patients who continued to have seizures. At 6 months follow up only 5 patients had 
seizures. All these patients had calcifications in C.T. scan. Patients who had their sizes 
increased in CT at 3 months decreased in size when compared to the initial CT scan 
taken at  the time of seizure occurrence for  the first  time.  At 1 year  only 5 patients 
continued to have seizures. Their seizure semiology were the same as before. AED’s 
were continued in these patients.
In  summary  predominant  presentation in our patients was GTCS followed by 
focal  seizures  with secondary generalization. Seizures are acute symptomatic in nature 
and most of the patients had adequate seizure control. Recurrent seizures were common 
in calcified lesion. All calcifications did not cause seizures. Why some patients with 
calcifications cause seizures while others remain asymptomatic is a matter of debate?. 
Recent evidence  suggest that mild inflammation may persist in the calcified stage in 
some cases, and may be associated with an increased risk for ongoing seizures 33. 
There are several hypotheses that might explain this apparent relapse of disease. 
Cerebral  edema may have resulted from the death of  parasites  that  were viable  and 
incompletely calcified. Alternatively, antigen release from several dead and involuted, 
calcified parasites might have produced  cerebral  edema. However, it  is  difficult  to 
understand  why  numerous  parasites  would   have  died  or  released  antigen 
simultaneously.  A  more  plausible  hypothesis  is  that  a  spontaneous   increase  in 
immunity, possibly triggered by the release  of antigen from a live or dying parasite, led 
to an intense immune response to antigen at the site of a calcified  lesion. 
Alternatively, another unrelated event, the immunologic reaction, might   have led 
to a generalized enhancement of cellular immunity, which in turn was directed against 
cysticercal  antigen  associated  with  several  dead calcified  lesions.  This  upgrading of 
immunity would be analogous to the treatment-induced or spontaneous enhancement of 
cell-mediated  immunity  associated  with  the  reversal  reaction  of  leprosy.  This 
phenomenon might help to explain why several calcified lesions might simultaneously 
develop a surrounding inflammatory response associated with edema. These are several 
hypothesis which are given for seizures occurring in a calcified lesion, by Tarang N.et 
al, in their case report of reactivation of neurocysticercosis 33.
Another feature which was noted was the presence of headache in patients with 
calcification. Among the patients who had calcification in their CT developed headache 
which  was  had  the  characteristics  of  migrainous  headache  without  aura.  Headache 
started after 2-4 months of the first episode of seizure in 6 patients and the headaches 
occur  at  a  frequency of  2-4 episodes  per  month.  All  these  patients  underwent  EEG 
testing to rule out a ictal headache. All the EEG’s were normal. Headaches occurred 
only in patients with calcifications.  The presence of headache could be the calcified 
lesion  acting  as  a  trigger  for  the  trigemino  thalamic  pain  pathway  by  irritating  the 
arachnoid  granulations  or  dural  sinus  which  are  pain  sensitive.  Another  plausible 
hypothesis is headache occurring as an ictal phenomenon, but EEG was obtained in our 
patients  were  normal.  However  these  recordings  were  interictal  recordings.  The 
occurrence of headache is discussed by Dr.Garg etal and Delbrutto etal 10,11,28,29. 
RADIOLOGICAL FEATURES
16 out of 25 patients had SSECT in parietal cortex, while 7 had in frontal lobe, 1 
each in occipital and temporal lobe.
The predeliction for parietal lobe for SSECT corresponds to most other studies 
4,8,10.Among the 25 patients 12 patients had scolex in their initial CT while 4 patients had 
central dot sign. When contrast was given the enhancement pattern of the lesions were 
19  had  ring  enhancement,4  had  disc  enhancement  and  2  patients  had  dough  nut 
enhancement.  The  presence  of  disc  enhancement  and  doughnut  enhancement 
corresponds to nodular granular stage of neurocysticercosis. The different patterns of 
enhancement is similar to what was noticed by Chandy etal  7,8 and their pathological 
correlation is similar to the study by Escobar etal  9. All patients had a complete ring 
enhancement on contrast examination and their sizes ranged from 10-20 mm in size. The 
presence of central dot sign which was initially thought to be a pointer to tuberculoma 
but it does occur in metastasis as well as neurocysticercosis.
At 3 months,  12 (48%) patients  had complete resolution,  3(12%) patients  had 
calcifications in the corresponding areas while two patients(8%) showed increase in size 
while  in  the other  patients  sizes  had  reduced.  Resolution by  calcification is  a  well 
known occurrence in SSECT and could be considered as natural evolution of the lesion. 
Why  some  lesions  disappear  while  some  calcify,  depends  on  the  immunity  of  the 
patient. 
The  exact  reason  is  not  known.  Rajshekhar  7,8,  in  a  prospective  study  of  210 
patients,  observed that single enhancing lesions completely resolved at different time 
intervals.  At  3  months  only  19% of  the  lesion  had  completely  resolved;  at  1  year 
approximately 63% had disappeared. In another prospective study, which fits with the 
majority opinion, Singh, et al.,10 observed that approximately 73% of similar-appearing 
lesions had disappeared within 2 months of their first CT documentation. Because of 
these conflicting observations, it is very difficult to recommend guidelines concerning 
the  need  and  timing  of  obtaining  follow-up  CT  scans  in  these  patients.  Hence 
controversy exists regarding the exact time that these CT-enhancing lesions disappear. 
In several retrospective studies the authors have suggested that spontaneous resolution 
may vary from as early as 6 weeks to as late as 75 weeks 9. Even greater persistence has 
been observed. Various authors have noted a wide variation in the rates of complete 
resolution.
Two patients had size of lesion increased at 3 months and we had one patient who 
at 3 months developed multiple ring enhancing lesions in CT and hence excluded from 
the  study.  Paradoxical  response  is  well  known  in  tuberculomas  and  it  is  a 
hypersensitivity reaction to ATT. But in our patients ATT was not started and still 1 
patient had this response. Infact it could not be called a paradoxical enlargement. Two 
patients who had increase in size of lesion where still continued only on AED’s and 
were followed up. 
Singh and associates reported two patients in whom even enlarged CT-evidenced 
lesions resolved spontaneously. Rajshekhar and Chandy 7,8 postulated two mechanisms 
for  the  enlargement  of  the  cysticercus  granulomas.  One  was  simply  an  increasing 
amount  of  inflammatory  reaction  giving  rise  to  an  increase  in  the  size  of  the  ring 
enhancing lesion as well as the surrounding oedema. The second mechanism involved 
two  cysticercus  cysts  located  in  proximity  to  each  other,  the  degeneration  of  one 
following the other very closely. 
Rajshekhar and Chandy, based on their experience of 3 patients, suggested that 
the enlarging cysticercus granulomas may be conservatively managed with a trial  of 
albendazole therapy. On the contrary, Singh etal believe that albendazole therapy was 
the cause of  enlargement of  the CT lesions.  In our patients,  at  6 months their  sizes 
decreased and both calcified at  1 year.  Paradoxical  enlargement of the lesion in our 
patients  was  noted even without  treatment.  The reason could be the patient  became 
symptomatic when the cyst was evolving in its size. This finding is important because 
some lesions  which  are  bigger  than  20mm in  size  could  be  cysticercosis  and some 
lesions which are less than 20mm could be tuberculomas and the clinico radiological 
classification is just a clinical pointer and each patient may behave differently and it 
depends upon the relationship between the host and the cyst/tubercle bacilli. In effect in 
our two patients we had not treated them with albendazole initially or even when they 
had enlargement at  3 months.  On follow up they calcified.  The exact  reason for the 
enlargement  is  still  debatable  and  that  it  can  occur  even  without  treatment  gives 
credence to the postulations made by Rajasekhar etal  7,8.
The common denominator in all patients with SSECT was almost all the lesions 
either  resolved  without  any  residua  in  CT  or  resolved  with  calcification.  Between 
calcification  and  complete  resolution  by  resorption  complete  resolution  was  more 
common rather than calcification, in our study. This conforms with most other studies 
which have been done previously. 
Until recently, if single enhancing lesions did not disappear or regress within a 
reasonable time period (usually within 6 months), they were viewed with suspicion and 
often  alternative  diagnoses  such  as  tuberculoma,  pyogenic  abscesses,  or  metastatic 
lesions  were  considered.  Some authors  have  contended  that  "persistence"  of  lesions 
indicates that more aggressive treatment or brain biopsy sampling may be necessary. 
Currently it  is  very difficult  to set  a  cutoff period after which these lesions may be 
termed persisting. In a recent prospective follow-up study, Rajshekhar 7,8 noted that the 
longer  the  follow-up  period  the  higher  the  number  of  cases  in  which  spontaneous 
disappearance of the granuloma occurred. He observed that at 6 months in only 19% of 
210 patients had complete resolution occurred whereas at the end of 1 year and 2 years, 
respectively,  in  approximately  63  and  89%  of  patients  CT  scans  revealed  normal 
findings. Garg and Nag 10 11 also reported similar observations in a retrospective study. 
They observed that in 16 of 101 patients the lesions did not disappear or regress after 6 
months.  Additional  follow-up scans  in  these  16 patients,  however,  revealed  that  the 
lesion eventually calcified in four patients, the ring lesions changed to disc lesion and 
degree  of  associated  edema  was  considerably  less  in  four,  and  the  lesion  persisted 
unchanged in the remaining eight. 
Although concern is often expressed, in none of the prospective and retrospective 
follow-up studies has either clinical deterioration or significant enlargement of lesions 
been  noted.  In  several  uncontrolled  series,  albendazole  therapy  has  been  shown  to 
produce  complete  resolution  of  persisting  lesions.  In  our  study  lesions  which  had 
persisted and which showed paradoxical enlargement either disappeared or calcified by 
one year in all these patients. Hence a longer follow up is essential even in patients who 
have single enhancing lesions.
There are conflicting views about the role of anticysticercal drugs in the management of 
single enhancing CT lesions. Prospective randomized studies on the role of steroid and 
albendazole are at best rare. Our study clearly suggests that therapy is not necessary for 
single  enhancing  CT lesions.  Seizure  recurrences  were  infrequent.  However  a  large 
sample size study may be required to substantiate this study.
                            CONCLUSIONS
1) By three months most of the SSECT resolve without calcification and by 1 year all 
lesions resolve either by resolution or calcification.
2) Enlargement of a lesion may not be always paradoxical and it  can be a natural 
course in the evolution of the lesion. 
3) SSECT  present  as  generalized  tonic  clonic  convulsions  or  focal  seizure  with 
secondary generalization.
4) Seizure caused by SSECT are well controlled and most of them don’t have seizures 
beyond 3 months.
5) Patients who have seizures are usually secondary to calcified lesions.
6) Specific treatment in terms of anticysticidal or ATT is unnecessary as all lesions 
have better seizure control and radiological resolution when followed for 1 year.
7) Steroids might be useful in patients who have lesion with significant oedema.
8) Headache is a feature of calcified lesion.
9) The commonest location of SSECT in brain is parietal cortex.
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ABBREVIATIONS AND ACRONYMS
 SSECT : Small Single Enhancing Lesion in CT
 EEG : Electro Encephalo Gram.
 CSF : Cerebro Spinal Fluid.
 CT : Computerized Tomogram.
 MRI : Magnetic Resonance Imaging.
 GTCS : Generalized Tonic-Clonic Seizure
 FS : Focal seizure 
 FSGS : Focal seizure with secondary generalisation.
 CPS : Complex partial seizure.
 AED : Antiepileptic Drug
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PATIENT  PROFORMA FOR SSECT LESION OF THE BRAIN, CLINICAL 
AND RADIOLOGICAL OUTCOME
NAME                              AGE         SEX           IP.,NO.,            MIN.,NO.,
ADDRESS  
CLINICAL HISTORY
SYMPTOMS.
HEADACHE
SEIZURES:
                   GTCS :
                  
                   SPS.
                   
                   CPS.
                   
                   FOCAL WITH SECONDARY GENERALISATION:
OTHER NEUROLOGICAL DEFICITS:
PAST AND PERSONAL HISTORY:
FAMILY HISTORY
ANY OTHER DETAILS
CLINICAL FINDINGS
PROBABLE DIAGNOSIS
INVESTIGATIONS
HAEMOGRAM,                            URINE                       STOOL.
MANTOUX,                                  SPUTUM FOR AFB          CHEST XRAY.
CT SCAN PLAIN                         
                  CONTRAST    
EEG
OTHER INVESTIGATIONS
FOLLOW UP
SYMPTOMS.
HEADACHE
SEIZURES
NEUROLOGICAL DEFICITS
SYMPTOM ANALYSIS
REPEAT CT SCANS AT 3 MONTHS AND 6 MONTHS      
MASTER CHART
Sl.No. Name Age Sex
AT THE TIME OF PRESENTATION
Type of 
Seizure Site of Lesion
Type of 
enhancement
1 Karthik 14 m SPS PARIETAL RING
2 Senthamarai 49 f GTCS PARIETAL RING
3 Vinodh 16 m GTCS FRONTAL RING
4 Prasadh 32 m GTCS PARIETALRING
5 Durai 62 M GTCS FRONTAL RING
6 Kani 48 f FSGS PARIETAL DISC
7 Nandhini 46 f GTCS PARIETALRING
8 Ashwini 34 f GTCS PARIETAL RING
9 Chellamal 36 f GTCS FRONTAL RING
10 Kannan 15 m FSGS PARIETAL RING
11 Selvam 33 m FSGS PARIETAL DISC
12 Kanmani 19 f GTCS FRONTAL RING
13 Suresh 28 m SPS PARIETAL DISC
14 Sherin 18 f FSGS PARIETAL RING
15 Vijaya 22 f CPS TEMPORAL RING
16 Yasodha 16 f GTCS PARIETAL RING
17 Prabhu 26 m GTCS FRONTAL RING
18 Chandran 48 m FSGS PARIETAL DOUGHNUT
19 Megathoth 38 m GTCS OCCIPITL DISC
20 Sundar 51 m GTCS FRONTAL RING
21 Kalaiarasan 30 m FSGS FRONTAL RING
22 Vetriselvi 33 f GTCS PARIETAL RING
23 Kalai 48 f FSGS PARIETAL DOUGHNUT
24 Gnanam 52 m GTCS FRONTAL RING
25 Sankar 36 m SPS FRONTAL RING
Sl.No. Name
THREE MONTHS SIX MONTHS
Type of 
Seizure
Radiological 
Outcome
Type of 
Seizure
Radiological 
Outcome
1 Karthik Resolution
2 Senthamarai Decreased Resolution
3 Vinodh Resolution
4 Prasadh Decreased Resolution
5 Durai Resolution
6 Kani Decreased Calcified
7 Nandhini Resolution
8 Ashwini GTCS Increased GTCS Decreased
9 Chellamal GTCS Decreased Resolution
10 Kannan Resolution
11 Selvam FSGS Decreased FSGS Calcified
12 Kanmani Resolution
13 Suresh Decreased Resolved
14 Sherin Resolution Calcified
15 Vijaya CPS Calcified CPS
16 Yasodha Resolution
17 Prabhu GTCS Calcified GTCS
18 Chandran FSGS Decreased Calcified
19 Megathoth Resolution
20 Sundar Decreased Resolution
21 Kalaiarasan FSGS Increased FSGS Decreased
22 Vetriselvi Resolution
23 Kalai Resolution
24 Gnanam Resolution
25 Sankar Calcified
Sl.No. Name
ONE YEAR
Type of 
eizure
Radiological 
Outcome
FINAL 
OUTCOME
IN CT
1 Karthik Resolution
2 Senthamarai Resolution
3 Vinodh Resolution
4 Prasadh Resolution
5 Durai Resolution
6 Kani Calcified
7 Nandhini Resolution
8 Ashwini GTCS Calcified Calcified
9 Chellamal Resolution
10 Kannan Resolution
11 Selvam FSGS Calcified
12 Kanmani Resolution
13 Suresh Resolution
14 Sherin Calcified
15 Vijaya CPS Calcified
16 Yasodha Resolution
17 Prabhu GTCS Calcified
18 Chandran Calcified
19 Megathoth Resolution
20 Sundar Resolution
21 Kalaiarasan Resolution Resolution
22 Vetriselvi Resolution
23 Kalai Resolution
24 Gnanam Resolution
25 Sankar Calcified
